Cordyceps sinensis market seen topping $2 billion by 2030

The cordyceps sinensis market is projected to grow at a 9.7% CAGR through 2030, powered by demand for natural supplements, sports nutrition and functional foods. The U.S. is expected to remain the largest national market, while dried products continue to dominate sales.

Why it matters: - Cordyceps sinensis is moving from a niche herbal ingredient into a broader wellness category as consumers seek natural, plant- and fungus-based supplements. - The market’s projected growth points to rising demand in nutraceuticals, functional foods and sports nutrition. - The segment could also benefit suppliers, processors and retailers tied to premium wellness products.

What happened: - The Business Research Company said the global cordyceps sinensis market is projected to grow at a 9.7% CAGR through 2030. - The company’s Cordyceps Sinensis Global Market Report 2026 forecasts the global market will surpass $2 billion by 2030. - The U.S. is projected to reach $0.67 billion by 2030, up from $0.42 billion in 2025. - North America is expected to be the largest regional market in 2030, with sales of $0.75 billion.

The details: - Dried cordyceps sinensis is expected to hold 71% of the market in 2030, worth about $1 billion. - The report splits the market by cultivation method into natural and artificial categories. - The report also divides applications into treatment-focused uses and broader healthcare uses. - The nutraceutical sector is projected to be worth about $835 billion by 2030, and cordyceps sinensis is expected to account for about 0.3% of that market. - The wider pharmaceuticals industry is forecast at $2,496 billion by 2030, with cordyceps sinensis representing close to 0.1% of the market. - The report says natural and organic supplement demand is a major growth driver, adding about 1.5% annual growth. - Expanded health awareness around immunity, energy and performance contributes an estimated 1.0% yearly growth. - Sports nutrition and functional food use is adding about 0.8% annual growth. - Together, the dried and wet product segments are projected to add more than $1.2 billion in market value by 2030. - Dried products are expected to add about $1 billion, while wet products are expected to add about $0.2 billion between 2025 and 2030.

Between the lines: - The market remains highly fragmented, with the top 10 companies accounting for only 5% of revenue in 2025. - Low to moderate barriers to entry help keep the field open, though quality standards, sourcing authenticity and regulatory requirements still matter. - Tong Ren Tang held the top global sales spot in 2025 with a 1% share. - Himalaya Herbal Healthcare also held about a 1% share in 2025. - Other notable competitors include Naturalin Bio-Resources, Nutra Green Biotechnology, Huisong Pharmaceuticals, Nammex, Dragon Herbs, Host Defense Mushrooms, NOW Foods and Real Mushrooms. - The report points to premium wellness retail and stronger consumer education as ways brands are expanding trust and access. - In June 2026, HEC Group opened its first overseas flagship store, HEC Life+, at Marina Bay Sands in Singapore. - The company framed the move around cultivation expertise, research-driven formulations and consumer education.

What's next: - Cordyceps brands are expected to keep investing in cultivation technology, extraction methods and processing improvements. - The report expects more research and biotechnology integration to improve standardization and production scale. - Distribution is likely to keep expanding through specialty retailers, online channels and premium wellness stores. - The report lists the company’s sample request and full report pages for readers seeking more detail: Request a free sample and Read the full report.

The bottom line: - Cordyceps sinensis is set for steady growth through 2030, led by natural supplement demand, premium wellness positioning and wider use in performance-focused products.